Overall, these results are in keeping with data by Blume et al. [12], showing that basal NEAT1 expression level is quite similar in CLL patients with a wild-type TP53 status or in those carrying TP53 alteration (i.e., mutation and/or deletion). This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.